Abstract: The invention relates to the field of flow cytometry and more particularly to a panel of antibody reagents conjugated to fluorescent compounds. Provided are reagent compositions, comprising at least eight distinct fluorochrome-conjugated antibodies comprising a set of at least there identification antibodies for the identification of a leukocyte population of interest and at least four characterization antibodies for further characterization and/or classification of said leukocyte population. Also provided are kits and methods related to the reagent compositions.

Abstract: The invention relates to the field of flow cytometry and more particularly to a panel of antibody reagents conjugated to fluorescent compounds. Provided are reagent compositions, comprising at least eight distinct fluorochrome-conjugated antibodies comprising a set of at least there identification antibodies for the identification of a leukocyte population of interest and at least four characterization antibodies for further characterization and/or classification of said leukocyte population. Also provided are kits and methods related to the reagent compositions.

Abstract: The invention relates to polymer-drug conjugate for delivering a substituted alkanoic acid non-steroidal anti-inflammatory drug (NSAID). The invention also relates to drug delivery systems comprising the polymer-NSAID conjugate. The polymer-NSAID conjugates comprise a substituted alkanoic acid non-steroidal anti-inflammatory drug (NSAID) conjugated to a biodegradable polymer backbone by an ester linkage.

Abstract: The invention relates to the field of flow cytometry and more particularly to a panel of antibody reagents conjugated to fluorescent compounds. Provided are reagent compositions, comprising at least eight distinct fluorochrome-conjugated antibodies comprising a set of at least there identification antibodies for the identification of a leukocyte population of interest and at least four characterization antibodies for further characterization and/or classification of said leukocyte population. Also provided are kits and methods related to the reagent compositions.

Abstract: A reciprocating scraper blade apparatus and method providing a multi-blade unit removably mounted upon a support unit that fits the receiver of a standard reciprocating saw and positions the multi-blade unit for efficient use, with a reciprocating saw, on workpieces situated in various floor, wall, and ceiling orientations, and having various corners, crevices, and grooves, allowing safe and secure placement and manipulation of the reciprocating saw in relation to the workpiece, and allowing safe and efficient scraping of the workpiece, including its corners, crevices, and grooves.

Abstract: In one embodiment, a permanent magnet rotor is provided. The permanent magnet rotor includes a shaft comprising an outer diameter, a first hub coupled about the shaft outer diameter, and a first plurality of pole pieces positioned radially about the hub. The rotor further includes a plurality of permanent magnets positioned radially about the hub. The plurality of pole pieces and the plurality of permanent magnets define a rotor outer diameter, and the rotor outer diameter is magnetically isolated from shaft.

Abstract: The invention relates to the field of flow cytometry and more particularly to a panel of antibody reagents conjugated to fluorescent compounds. Provided are reagent compositions, comprising at least eight distinct fluorochrome-conjugated antibodies comprising a set of at least three identification antibodies for the identification of a leukocyte population of interest and at least four characterization antibodies for further characterization and/or classification of said leukocyte population. Also provided are kits and methods related to the reagent compositions.

Abstract: Resolving conflicting changes to structured data files. A method includes for a structured data file which has both a generic structure and dialects built on top of the generic structure, for which conflicting changes have been made, and where an original version of the structured data, a first version of the structured data and a second version of the structured data exist, determining a dialect of the structured data. The method further includes, based on the determined dialect performing at least one of merge or diff operations on the original version of the structured data, the first version of the structured data and the second version of the structured data.

Abstract: The present invention relates in general to polymer-bioactive agent conjugates for delivering a bioactive agent to a subject. The polymer-bioactive agent conjugates contain triazole moieties in the polymer backbone and a bioactive moiety selected from prostaglandin analogues, .beta.-blockers and mixtures thereof. The present invention also relates to methods for preparing the polymer conjugates using click chemical reactions, to monomer-bioactive agent conjugates suitable for preparing the polymer conjugates, and to pharmaceutical products comprising the polymer conjugates for the treatment of glaucoma.

Abstract: A method for determining the presence of a copy number imbalance in genomic DNA of a test sample is provided. The method can separately measure hybridization of a single test sample to a first hybridization array and hybridization of a plurality of reference samples to a plurality of other, respective test arrays. A determination of copy number can be based on the best fit reference array, relative to the test array. The best fit can be determined based on the closest or most similar signal-to-noise ratio of the measured signals.

Abstract: The present invention relates in general to polymer-bioactive agent conjugates for delivering a bioactive agent to a subject. The polymer-bioactive agent conjugates contain triazole moieties in the polymer backbone and a bioactive moiety comprising prostaglandin analogues. The present invention also relates to methods for preparing the polymer conjugates using click chemical reactions, to monomer-bioactive agent conjugates suitable for preparing the polymer conjugates, and to pharmaceutical products comprising the polymer conjugates for the treatment of glaucoma.

Abstract: In embodiments of restricted execution modes, a mobile device can display a device lock screen on an integrated display device, and transition from the device lock screen to display a shared space user interface of a shared space. The transition to display the shared space user interface is without receiving a PIN code entered on the device lock screen. The mobile device implements a restricted execution service that is implemented to activate a restricted execution mode of the mobile device, and restrict access of a device application to device content while the restricted execution mode is activated. The restricted execution service can also allow a shared device application that is included in the shared space access to the device content while the restricted execution mode is activated.

Abstract: A method for determining the presence of a copy number imbalance in genomic DNA of a test sample is provided. The method can separately measure hybridization of a single test sample to a first hybridization array and hybridization of a plurality of reference samples to a plurality of other, respective test arrays. A determination of copy number can be based on the best fit reference array, relative to the test array. The best fit can be determined based on the closest or most similar signal-to-noise ratio of the measured signals.

Abstract: The present invention relates in general to polymer-bioactive agent conjugates for delivering a bioactive agent to a subject. The polymer-bioactive agent conjugates contain triazole moieties in the polymer backbone and a bioactive moiety selected from prostaglandin analogs, ?-blockers and mixtures thereof. The present invention also relates to methods for preparing the polymer conjugates using click chemical reactions, to monomer-bioactive agent conjugates suitable for preparing the polymer conjugates, and to pharmaceutical products comprising the polymer conjugates for the treatment of glaucoma.

Abstract: Resolving conflicting changes to structured data files. A method includes for a structured data file which has both a generic structure and dialects built on top of the generic structure, for which conflicting changes have been made, and where an original version of the structured data, a first version of the structured data and a second version of the structured data exist, determining a dialect of the structured data. The method further includes, based on the determined dialect performing at least one of merge or diff operations on the original version of the structured data, the first version of the structured data and the second version of the structured data.

Abstract: Systems and methods for identifying equivalent content items. A computer system may receive a description of a first content item, the description of the first content item comprising a first set of values for a plurality of content item characteristics. The computer system may compare the first content item to each of a plurality of content items. The comparing may comprise, for each combination of the first content item and one of the plurality of content items, identifying any characteristics from the plurality of content item characteristics for which first content item and the one of the plurality of content items has equivalent values. The computer system may identify at least one content item selected from the plurality of content items. The first content item and the at least one content item have equivalent values for a predetermined pattern of the plurality of content item characteristics.

Abstract: A method for testing configuration of environments is provided. A probe for connection to a network and/or devices interacts to launch a configuration analyzer tool. The configuration analyzer tool includes a test mechanism for running a set of tests for the probe relating to connectivity and configuration of attached networks and devices before connection and suggesting solutions to test results. The tests may be externalized and dynamically loaded at run time of the configuration analyzer tool.

Abstract: The present invention relates to phenyl amino pyrimidine compounds which are inhibitors of protein kinases including JAK kinases. In particular the compounds are selective for JAK2 kinases. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases; and vascular diseases.

Abstract: The presentinvention relates in general to polymer-bioactive agent conjugates for delivering a bioactive agent to a subject. The polymer-bioactive agent conjugates contain triazole moieties in the polymer backbone and a bioactive moiety selected from prostaglandin analogues, ?-blockers and mixtures thereof. The present invention also relates to methods for preparing the polymer conjugates using click chemical reactions, to monomer-bioactive agent conjugates suitable for preparing the polymer conjugates, and to pharmaceutical products comprising the polymer conjugates for the treatment of glaucoma.

Abstract: In embodiments of mobile device child share, a mobile device can display a default device lock screen on an integrated display device, and receive an input effective to transition from the default device lock screen to display a child lock screen without receiving a PIN code entered on the default device lock screen. The mobile device can receive a second input effective to transition from the child lock screen to display a child space. The mobile device implements a device share service that activates a child share mode of the mobile device, and restricts functionality of device applications and access to device content based on designated restriction limits.